| Year |
Citation |
Score |
| 2016 |
Sulzmaier FJ, Young-Robbins S, Jiang P, Geerts D, Prechtl AM, Matter ML, Kesari S, Ramos JW. RSK2 activity mediates glioblastoma invasiveness and is a potential target for new therapeutics. Oncotarget. PMID 27829215 DOI: 10.18632/Oncotarget.13084 |
0.659 |
|
| 2016 |
Fash DM, Peer CJ, Li Z, Talisman IJ, Hayavi S, Sulzmaier FJ, Ramos JW, Sourbier C, Neckers L, Figg WD, Beutler JA, Chain WJ. Synthesis of a stable and orally bioavailable englerin analogue. Bioorganic & Medicinal Chemistry Letters. PMID 27107948 DOI: 10.1016/J.Bmcl.2016.04.016 |
0.603 |
|
| 2015 |
Liang Z, Sulzmaier FJ, Yoshida WY, Kelly M, Ramos JW, Williams PG. Neopetrocyclamines A and B, polycyclic diamine alkaloids from the sponge Neopetrosia cf exigua. Journal of Natural Products. 78: 543-7. PMID 25585025 DOI: 10.1021/Np500759R |
0.581 |
|
| 2014 |
Fernández-Gallardo J, Elie BT, Sulzmaier FJ, Sanaú M, Ramos JW, Contel M. Organometallic Titanocene-Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties. Organometallics. 33: 6669-6681. PMID 25435644 DOI: 10.1021/Om500965K |
0.631 |
|
| 2014 |
Sulzmaier FJ, Jean C, Schlaepfer DD. FAK in cancer: mechanistic findings and clinical applications. Nature Reviews. Cancer. 14: 598-610. PMID 25098269 DOI: 10.1038/nrc3792 |
0.362 |
|
| 2014 |
Tancioni I, Uryu S, Sulzmaier FJ, Shah NR, Lawson C, Miller NL, Jean C, Chen XL, Ward KK, Schlaepfer DD. FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth. Molecular Cancer Therapeutics. 13: 2050-61. PMID 24899686 DOI: 10.1158/1535-7163.MCT-13-1063 |
0.373 |
|
| 2014 |
Tancioni I, Uryu S, Sulzmaier F, Shah N, Lawson C, Miller NLG, Jean C, Chen XL, Ward KK, Schlaepfer DD. Abstract 752: Genetic and pharmacological FAK inhibition disrupt a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth Cancer Research. 74: 752-752. DOI: 10.1158/1538-7445.Am2014-752 |
0.446 |
|
| 2013 |
Sulzmaier FJ, Ramos JW. RSK isoforms in cancer cell invasion and metastasis. Cancer Research. 73: 6099-105. PMID 24097826 DOI: 10.1158/0008-5472.Can-13-1087 |
0.696 |
|
| 2012 |
Sulzmaier FJ, Li Z, Nakashige ML, Fash DM, Chain WJ, Ramos JW. Englerin a selectively induces necrosis in human renal cancer cells. Plos One. 7: e48032. PMID 23144724 DOI: 10.1371/Journal.Pone.0048032 |
0.635 |
|
| 2012 |
Gawecka JE, Young-Robbins SS, Sulzmaier FJ, Caliva MJ, Heikkilä MM, Matter ML, Ramos JW. RSK2 protein suppresses integrin activation and fibronectin matrix assembly and promotes cell migration. The Journal of Biological Chemistry. 287: 43424-37. PMID 23118220 DOI: 10.1074/Jbc.M112.423046 |
0.717 |
|
| 2012 |
Sulzmaier F, Opoku-Ansah J, Ramos JW. Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small Gtpases. 3: 173-7. PMID 22694972 DOI: 10.4161/Sgtp.20021 |
0.646 |
|
| 2012 |
Gawecka JE, Geerts D, Koster J, Caliva MJ, Sulzmaier FJ, Opoku-Ansah J, Wada RK, Bachmann AS, Ramos JW. PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. International Journal of Cancer. 131: 1556-68. PMID 22213050 DOI: 10.1002/Ijc.27415 |
0.721 |
|
| 2012 |
Sulzmaier FJ, Valmiki MK, Nelson DA, Caliva MJ, Geerts D, Matter ML, White EP, Ramos JW. PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D. Oncogene. 31: 3547-60. PMID 22105357 DOI: 10.1038/Onc.2011.514 |
0.625 |
|
| 2012 |
Williams P, Preciado A, Liang Z, Sulzmaier F, Ramos J. Stictamides - Isolation, synthesis, and biological evaluation of cell invasion inhibitors Planta Medica. 78. DOI: 10.1055/S-0032-1320313 |
0.631 |
|
| 2011 |
Liang Z, Sorribas A, Sulzmaier FJ, Jiménez JI, Wang X, Sauvage T, Yoshida WY, Wang G, Ramos JW, Williams PG. Stictamides A-C, MMP12 inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid subunits. The Journal of Organic Chemistry. 76: 3635-43. PMID 21500817 DOI: 10.1021/Jo200241H |
0.602 |
|
| 2011 |
Griffiths GS, Grundl M, Leychenko A, Reiter S, Young-Robbins SS, Sulzmaier FJ, Caliva MJ, Ramos JW, Matter ML. Bit-1 mediates integrin-dependent cell survival through activation of the NFkappaB pathway. The Journal of Biological Chemistry. 286: 14713-23. PMID 21383007 DOI: 10.1074/Jbc.M111.228387 |
0.699 |
|
| 2010 |
Pastorino S, Renganathan H, Caliva MJ, Filbert EL, Opoku-Ansah J, Sulzmaier FJ, Gawecka JE, Werlen G, Shaw AS, Ramos JW. The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 2818-28. PMID 20354143 DOI: 10.1096/Fj.09-144295 |
0.57 |
|
| Show low-probability matches. |